Citadel Advisors’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Sell |
175,253
-963,665
| -85% | -$25.1M | ﹤0.01% | 2011 |
|
|
2025
Q1 | $27.9M | Sell |
1,138,918
-30,335
| -3% | -$743K | 0.01% | 727 |
|
|
2024
Q4 | $33.5M | Buy |
1,169,253
+847,890
| +264% | +$24.3M | 0.01% | 703 |
|
|
2024
Q3 | $12.1M | Sell |
321,363
-170,331
| -35% | -$6.43M | ﹤0.01% | 1127 |
|
|
2024
Q2 | $15.5M | Buy |
491,694
+215,233
| +78% | +$6.79M | ﹤0.01% | 994 |
|
|
2024
Q1 | $12.1M | Buy |
+276,461
| New | +$12.1M | ﹤0.01% | 1179 |
|